Biopharmaceutical Cold Chain Logistics Market Report 2026

Biopharmaceutical Cold Chain Logistics Market Overview

• Biopharmaceutical Cold Chain Logistics market size has reached to $16.47 billion in 2025 • Expected to grow to $25.87 billion in 2030 at a compound annual growth rate (CAGR) of 9.5% • Growth Driver: Rising Demand For Personalized Medicine Driving The Market Growth Due To Advances In Genomic Technologies And Increasing Approval Of Targeted Therapies • Market Trend: Advancements In IoT-Enabled Reusable Packaging Strengthen Biopharmaceutical Cold Chain Logistics • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Biopharmaceutical Cold Chain Logistics Market?

Biopharmaceutical cold chain logistics refers to the transportation and storage of biopharmaceutical products under strictly controlled temperature conditions to preserve their safety, stability, and efficacy. It ensures that sensitive products remain effective from manufacturing to end-user delivery. The main service types of biopharmaceutical cold chain logistics include transportation, storage, packaging, and other service types. Transportation refers to the organized movement of temperature-sensitive biopharmaceutical products from manufacturing facilities to storage or administration sites. The logistics cover product types such as vaccines, clinical trial materials, biopharmaceuticals, and other product types and the temperature range includes refrigerated, frozen, cryogenic, and other temperature ranges. The mode of transportation includes airways, roadways, seaways, and railways, while the end-users include pharmaceutical and biotechnology companies, healthcare providers, research institutes, and other end users.

What Is The Biopharmaceutical Cold Chain Logistics Market Growth Forecast?

The biopharmaceutical cold chain logistics market size is expected to see strong growth in the next few years. It will grow to $25.87 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to growing adoption of active temperature-controlled containers, increasing demand for cold chain monitoring services, rising deployment of reusable thermal packaging, expansion of short-term transit storage solutions, increasing integration with AI and IoT-enabled logistics systems. Major trends in the forecast period include increasing adoption of temperature-controlled packaging solutions, rising demand for last-mile cold chain delivery, growing integration of real-time cold chain monitoring, expansion of refrigerated and cryogenic storage facilities, rising focus on compliance and regulatory support services.

Global Biopharmaceutical Cold Chain Logistics Market Segmentation

1) By Service Type: Transportation, Storage, Packaging, Other Service Types 2) By Product Type: Vaccines, Clinical Trial Materials, Biopharmaceuticals, Other Product Types 3) By Temperature Range: Refrigerated, Frozen, Cryogenic, Other Temperature Ranges 4) By Mode Of Transportation: Airways, Roadways, Seaways, Railways 5) By End-User: Pharmaceutical And Biotechnology Companies, Healthcare Providers, Research Institutes, Other End Users Subsegments: 1) By Transportation: Refrigerated Road Transport, Temperature Controlled Air Freight, Insulated Sea Freight, Last Mile Cold Delivery 2) By Storage: Refrigerated Warehousing, Frozen Storage Facilities, Cryogenic Storage, Short Term Transit Storage 3) By Packaging: Passive Insulated Packaging, Active Temperature Controlled Containers, Reusable Thermal Packaging, Single Use Cold Chain Packaging 4) By Other Service Types: Cold Chain Monitoring Services, Validation And Qualification Services, Inventory Management Services, Regulatory Compliance Support Services

What Is The Driver Of The Biopharmaceutical Cold Chain Logistics Market?

The growing demand for personalized medicine is expected to propel the growth of the biopharmaceutical cold chain logistics market going forward. Personalized medicine is an approach that customizes healthcare and therapies based on a patient’s unique biological and personal characteristics. The use of personalized medicine is increasing due to advances in genomic technologies, which allow healthcare providers to analyze a patient’s genetic information quickly and accurately, enabling more targeted and effective treatments. Biopharmaceutical cold chain logistics support personalized medicine by maintaining the required temperature and handling conditions for individualized therapies, ensuring they remain effective and safe until delivered to patients. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. The newly approved personalized treatments for 2023 also include seven cancer drugs and three for other diseases and conditions. Therefore, the growing demand for personalized medicine is driving the growth of the biopharmaceutical cold chain logistics industry.

Key Players In The Global Biopharmaceutical Cold Chain Logistics Market

Major companies operating in the biopharmaceutical cold chain logistics market are Cencora Inc., DHL Group, United Parcel Service of America Inc., FedEx Corporation, A.P. Møller - Mærsk A/S, SF Holding Co. Ltd., Schenker AG, CEVA Logistics S.A., Nippon Express Holdings Inc., GXO Logistics Inc., Sonoco Products Company, Agility Public Warehousing Company K.S.C.P., Americold Realty Trust Inc., Marken Ltd., Pelican Products Inc., Cold Chain Technologies LLC, Controlant hf., Sensitech Inc., Envirotainer AB, QuickSTAT Global Life Science Logistics LLC, Cryopak Industries Inc., DGP Intelsius Ltd., Tower Cold Chain Solutions Ltd., and Snowman Logistics Limited.

Global Biopharmaceutical Cold Chain Logistics Market Trends and Insights

Major companies operating in the biopharmaceutical cold chain logistics market are focusing on developing innovative solutions such as reusable temperature-controlled pallet shippers to ensure safe, sustainable, and cost-efficient transport of temperature-sensitive biologics. A reusable temperature-controlled pallet shipper is a durable, multi-use container that maintains stable temperatures for safely transporting temperature-sensitive biopharmaceuticals. For instance, in April 2025, Cold Chain Technologies LLC, a US-based packaging company, launched a reusable CCT Tower Elite, a 1600 L temperature-controlled pallet shipper designed for life sciences logistics, featuring integrated IoT for real-time monitoring. It is designed to maintain stability over 120 hours at temperatures like <-60°C, +5°C, and +20°C using phase-change materials, supporting vaccines, biologics, and gene therapies in formats such as RoSS® shells and API drums. Its lightweight, aircraft-compatible build and global reuse network promote sustainability in pharma shipments.

What Are Latest Mergers And Acquisitions In The Biopharmaceutical Cold Chain Logistics Market?

In November 2025, UPS Healthcare Inc., a US-based healthcare logistics and supply chain company, acquired Andlauer Healthcare Group Inc. for an undisclosed amount. Through this acquisition, UPS Healthcare aims to strengthen its cold chain logistics capabilities by leveraging Andlauer Healthcare Group’s specialized temperature-controlled transportation and storage solutions, enabling more reliable delivery of temperature-sensitive pharmaceuticals and vaccines. Andlauer Healthcare Group Inc. is a Canada-based healthcare logistics company specializing in cold chain distribution and supply chain management for the healthcare sector.

Regional Insights

North America was the largest region in the biopharmaceutical cold chain logistics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Biopharmaceutical Cold Chain Logistics Market?

The biopharmaceutical cold chain logistics market consists of revenues earned by entities by providing services such as temperature-controlled transportation, cold storage and warehousing, packaging and conditioning, real-time temperature monitoring, regulatory compliance support, and last-mile distribution of biopharmaceutical products. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data And Analysis Are Included In The Biopharmaceutical Cold Chain Logistics Market Report 2026?

The biopharmaceutical cold chain logistics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the biopharmaceutical cold chain logistics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.